Automata, founded in 2015, is at the forefront of revolutionizing lab automation for the AI era. The company offers a fully integrated, AI-ready platform that is both modular and user-friendly, contrasting sharply with the fragmented and cumbersome legacy systems. Based in the United Kingdom, Automata operates primarily within the AI, Biotechnology, Life Sciences, and Robotics sectors.
The company's appeal lies in its ability to simplify and accelerate scientific discoveries, empowering researchers to focus on programming experiments rather than managing complex robotics.
In a promising Series C investment round completed on 01 January 2026, Automata raised $45.00M. Noteworthy investors in this round included Octopus Ventures, Entrepreneur First, Tru Arrow Partners, Dimension, and Danaher Life Science, underscoring the strong confidence in Automata's vision and growth trajectory.